Public (rebranded Claritev, NYSE: CTEV); underwent a reverse split
Live Β· CTEVΒ· NYSE
as of 2026-09-17
$31.73βΌ 13.64% today
βΒ $538 Million market cap Β· β95.1% from peak
The rise & fall
6 moments Β· 1980β2025
The key moments.
1980
π±
1980
Founded in New York
A claims-cost negotiator decades older than the unicorn era; years of private-equity ownership follow.
Wikipedia
Oct 2020
π
Oct 2020
The peak: an $11B de-SPAC$11B
Merges with Michael Klein's Churchill Capital Corp III β one of the largest SPAC deals of the era.
SEC filing
Nov 2020
Nov 2020
Muddy Waters takes aim
A short-seller report questions customer concentration weeks after the debut; heavy debt does the rest.
Reuters
2022
π
2022
Slips out of the club
The stock's long slide takes the equity below $1B.
PE Insights
2025
2025
Rebrands as Claritev
A new name (NYSE: CTEV) and a reverse split leave the equity at a fraction of its debut value.
PE Insights
Today
Today
Still in the club β and still trading
Live Β· CTEV Β· NYSEas of 2026-09-17
$31.73βΌ 13.64% todayβ $538M cap Β· β95.1% from peak
How it happened
MultiPlan provides data and analytics that health insurers use to cut medical-claims costs, and went public in October 2020 through an $11B SPAC merger with Michael Klein's Churchill Capital Corp III β one of the largest de-SPAC deals of the era.
Heavy debt, customer-concentration worries and a critical short-seller report battered the stock, which fell nearly 90% from its offering price. The company later rebranded as Claritev and executed a reverse split, leaving its equity worth a small fraction of its debut value.
Source: PE Insights / Claritev / SEC ($11B enterprise value via Churchill Capital Corp III SPAC, Oct 2020; stock -89%+ from offering; rebranded Claritev (CTEV) after a reverse split)
Who ran it
Travis Dalton
Chairman, President & CEO of MultiPlan/Claritev (since March 2024, current)
